Navigated to E117: Inebilizumab for IgG4-RD (MITIGATE)

E117: Inebilizumab for IgG4-RD (MITIGATE)

Dec 3, 2024
12 mins

Episode Description

New RCT in a new disease with a new drug! But is it as shiny as one would hope? Interesting discussion today about what a trial means, how it will affect practice, and how we could do better as a field. Happy holidays everyone! 

See all episodes

Never lose your place, on any device

Create a free account to sync, back up, and get personal recommendations.